Skip to main content

Jordi Navarro Mercadé

Institutions of which they are part

Main researcher
Infectious Diseases
Vall Hebron Institut de Recerca

Jordi Navarro Mercadé

Institutions of which they are part

Main researcher
Infectious Diseases
Vall Hebron Institut de Recerca

Projects

Malalties infeccioses

IP: Falcó Ferrer, Vicenç
Collaborators: Santos Santiago, Jose, Aznar Ruiz de Alegria, Maria Luisa, Curran Fàbregas, Adria, Garcia Perez, Jorge Nestor, Len Abad, Oscar, Ferrer Barberà, Mª Carmen, Gomis Rodriguez, Javier, Pou Ciruelo, Diana, Treviño Maruri, Begoña, Fernández Hidalgo, Nuria, Gavaldà Santapau, Joan, Espinosa Pereiro, Juan, Planas Ribas, Bibiana, Rodríguez Pardo, Ma Dolores, Bosch Nicolau, Pau, Perea Pérez, David, Molina Romero, Israel, Álvarez López, Patricia, Luis Lopez Perez, Descalzo Jorro, Vicente, Sanchiz Cruz, Marta, Serre Delcor, Nuria, Escola Verge, Laura, Sellares Nadal, Julia, Salvador Velez, Fernando M, Ruiz Camps, Isabel, Malalties infeccioses, Malalties infeccioses, Gómez i Prat, Jordi, Buzón Gómez, María José, Ouaarab Essadek, Hakima, Suanzes Diez, Paula, Navarro Mercadé, Jordi, Esteban Serna, Esperanza, Morales Martinez, Raisa, Burgos Cibrian, Joaquin, Sanchez Gaona, Nerea, Rey Cano, Joan, Sánchez Montalvá, Adrián, Mancebo Perez, Cristina, Montserrat Llinás Vidal, Malalties infeccioses, Gallego Cortes, Ana, Arando Lasagabaster, Maider, Los Arcos Bertiz, Ibai, Broto Cortes, Claudia, Ester Marquez Algaba, Benito Almirante Gragera, Desideria Martinez Rascón, Malalties infeccioses, Genesca Ferrer, Meritxell, Oliveira Souto, Ines Mercedes, Magnani , Silvina Andrea, Baktash , Yasmine Margaret, Malalties infeccioses
Funding agency: AGAUR no fer servir-correcte 4301-37
Funding: 60000
Reference: 2021 SGR 00764
Duration: 01/01/2022 - 31/12/2024

Impact of early treatment during acute HIV infection on the metabolism of reservoir and immune effector cells: Identification of new targets to reduce persistent HIV

IP: Navarro Mercadé, Jordi
Collaborators: Curran Fàbregas, Adria, Garcia Perez, Jorge Nestor, Falcó Ferrer, Vicenç, Planas Ribas, Bibiana, Descalzo Jorro, Vicente, Suanzes Diez, Paula, Grau Exposito, Judit
Funding agency: Instituto de Salud Carlos III
Funding: 87120
Reference: PI20/00823
Duration: 01/01/2021 - 30/06/2025

Desenvolupament de noves nanopartícules funcionals dirigides al nòdul limfàtic per a l'eliminació del reservori latent de VIH

IP: Buzón Gómez, María José
Collaborators: Abasolo Olaortua, Ibane, Pumarola Segura, Félix, Lorente Guerrero, Juan, Laura García Latorre, Temprana Salvador, Jordi, Joaquin Seras Franzoso, Pellicer Sarasa, Marc, Perea Pérez, David, Simon Schwartz Navarro, Navarro Mercadé, Jordi, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Grau Exposito, Judit, Genesca Ferrer, Meritxell, Fernanda Raquel Da Silva Andrade, Diana Fernandes de Rafael
Funding agency: Fundació La Marató de TV3
Funding: 199998.75
Reference: 20180510
Duration: 10/05/2019 - 31/12/2022

Incorporació Dr. Esteve Ribera a la RETICS en SIDA

IP: -
Collaborators: Curran Fàbregas, Adria, Falcó Ferrer, Vicenç, Inmaculada Ocaña Rivera, Caballero Requero, Estrella, Rando Segura, Ariadna, Perea Pérez, David, Soler Palacín, Pere, Buzón Gómez, María José, Suanzes Diez, Paula, Navarro Mercadé, Jordi, Burgos Cibrian, Joaquin, Sanchez Gaona, Nerea, Rey Cano, Joan, Incorporació Dr. Esteve Ribera a la RETICS en SIDA, Genesca Ferrer, Meritxell, Frick , Marie Antoinette, Curran Fàbregas, Adria, Curran Fàbregas, Adria, Curran Fàbregas, Adria, Curran Fàbregas, Adria, Curran Fàbregas, Adria, Curran Fàbregas, Adria, Curran Fàbregas, Adria, Curran Fàbregas, Adria, Curran Fàbregas, Adria, Curran Fàbregas, Adria, Curran Fàbregas, Adria, Curran Fàbregas, Adria, Curran Fàbregas, Adria, Curran Fàbregas, Adria, Curran Fàbregas, Adria, Curran Fàbregas, Adria, Curran Fàbregas, Adria
Funding agency: Instituto de Salud Carlos III
Funding: 247500
Reference: RD16/0025/0007
Duration: 01/01/2017 - 30/06/2022

Related news

The initiative, carried out at the Consulate of Bolivia, has resulted in 307 new tests for the diagnosis of Chagas disease

The study shows that blocking the KLRG1 receptor helps to recover the activity of the natural killer cells of the immune system and reactivate the virus reservoir to fight infection.

This new method improves and streamlines drug development processes

Related professionals

Tudela Trancoso, Miriam

Tudela Trancoso, Miriam

Shock, Organ Dysfunction and Resuscitation
Read more
Sergi Martí Beltran

Sergi Martí Beltran

Pneumology
Read more
Palmas Candia, Fiorella Ximena

Palmas Candia, Fiorella Ximena

Research technician
Diabetes and Metabolism
Read more
Montserrat García Portabella

Montserrat García Portabella

Reconstructive Surgery of the Locomotor System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.